DRUG · Mapped RxNorm record
Celecoxib
Normalized identity: celecoxibView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
NCT00068653
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
ZD1839
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedGefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
CelecoxibDRUG · verified · RxNorm: celecoxib
ZD1839DRUG
Sponsors & collaborators
Barbara Ann Karmanos Cancer Institutelead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00068653 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.